A novel fluorescent imaging agent for diffuse optical tomography of the breast: First clinical experience in patients

Molecular Imaging and Biology

Volumn 12, Issue 3, 2010, Pages 343-348

  Van De Ven, Stephanie ^a   Wiethoff, Andrea ^b   Nielsen, Tim ^c   Brendel, Bernhard ^c   Van Der Voort, Marjolein ^c   Nachabe, Rami ^c   Van Der Mark, Martin ^c   Van Beek, Michiel ^c   Bakker, Leon ^c   Fels, Lueder ^d   Elias, Sjoerd ^a   Luijten, Peter ^a   Mali, Willem ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PHILIPS HEALTHCARE   (United States)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

^d BAYER PHARMA AG   (Germany)

Author keywords

Breast cancer; Contrast agent; Detection; Diffuse optical tomography; Fluorescence; Molecular imaging

Indexed keywords

FLUORESCENT DYE; OMOCYANINE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY WEIGHT; BREAST CANCER; BREAST FIBROADENOMA; CANCER DIAGNOSIS; CANCER INVASION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE ESCALATION; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; PRIORITY JOURNAL; BREAST; BREAST TUMOR; CLINICAL TRIAL; DIFFUSION; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; DIFFUSION; FEMALE; FLUORESCENT DYES; HUMANS; MIDDLE AGED; TOMOGRAPHY, OPTICAL; YOUNG ADULT;

EID: 77956266597     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0269-1     Document Type: Article

References (23)

1. Cutler M (1929) Transillumination as an aid in the diagnosis of breast lesions. Surg Gynecol Obstet 48:721-728
2. Gibson AP, Hebden JC, Arridge SR (2005) Recent advances in diffuse optical imaging. Phys Med Biol 50(4):R1-43
3. Chance B, Nioka S, Zhang J et al (2005) Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 12(8):925-933
4. Floery D, Helbich TH, Riedl CC et al (2005) Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 40(6):328-335
5. Ntziachristos V, Yodh AG, Schnall MD, Chance B (2002) MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia 4(4):347-354
6. Rinneberg H, Grosenick D, Moesta KT et al (2005) Scanning timedomain optical mammography: detection and characterization of breast tumors in vivo. Technol Cancer Res Treat 4(5):483-496
7. Tromberg BJ, Cerussi A, Shah N et al (2005) Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women andmonitoring neoadjuvant chemotherapy. Breast Cancer Res 7(6):279-285
8. Zhu Q, Cronin EB, Currier AA et al (2005) Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology 237(1):57-66
9. Intes X (2005) Time-domain optical mammography SoftScan: initial results. Acad Radiol 12(8):934-947
10. Taroni P, Torricelli A, Spinelli L et al (2005) Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 50(11):2469-2488
11. Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ (2006) In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 11(4):044005
12. Leff DR, Warren OJ, Enfield LC et al (2007) Diffuse optical imaging of the healthy and diseased breast: a systematic review. Breast Cancer Res Treat 108(1):9-22
13. Hilger I, Leistner Y, Berndt A et al (2004) Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol 14(6):1124-1129
14. Montet X, Ntziachristos V, Grimm J, Weissleder R (2005) Tomographic fluorescence mapping of tumor targets. Cancer Res 65(14):6330-6336
15. Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R (2005) Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol 40(6):321-327
16. Intes X, Ripoll J, Chen Y, Nioka S, Yodh AG, Chance B (2003) In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 30(6):1039-1047
17. Ntziachristos V, Yodh AG, Schnall M, Chance B (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 97(6):2767-2772
18. Licha K, Riefke B, Ntziachristos V, Becker A, Chance B, Semmler W (2000) Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization P. Photochem Photobiol 72:392-398
19. Corlu A, Choe R, Durduran T et al (2007) Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Express 15(11):6696-6716
20. Van de Ven SMWY, Elias SG, Wiethoff AJ et al (2009) Diffuse optical tomography of the breast: initial validation in benign cysts. Mol Imaging Biol 11:64-70. doi:10.1007/s11307-008-0176-x
21. Nielsen T, Brendel B, Ziegler R, Uhlemann F, Bontus C, Koehler T (2008) Linear image reconstruction for a diffuse optical mammography system in a non-compressed geometry using scattering fluid. Biomedical Optics 2008; OSA Technical Digest: BMD23
22. Scherleiter E, Zagar BG (2005) Optical tomography imaging based on higher order born approximation of diffuse photon densitiy waves. IEEE Trans Instrum Meas 54(4):1607-1611
23. Rice A, Quinn CM (2002) Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. J Clin Pathol 55(8):569-574